147 related articles for article (PubMed ID: 27391090)
1. Preferentially Expressed Antigen of Melanoma Prevents Lung Cancer Metastasis.
Huang Q; Wei H; Wu Z; Li L; Yao L; Sun Z; Li L; Lin Z; Xu W; Han S; Cao W; Xu Y; Song D; Yang X; Xiao J
PLoS One; 2016; 11(7):e0149640. PubMed ID: 27391090
[TBL] [Abstract][Full Text] [Related]
2. PRAME is critical for breast cancer growth and metastasis.
Sun Z; Wu Z; Zhang F; Guo Q; Li L; Li K; Chen H; Zhao J; Song D; Huang Q; Li L; Xiao J
Gene; 2016 Dec; 594(1):160-164. PubMed ID: 27632898
[TBL] [Abstract][Full Text] [Related]
3. Identification of Preferentially Expressed Antigen of Melanoma as a Potential Tumor Suppressor in Lung Adenocarcinoma.
Huang Q; Li L; Lin Z; Xu W; Han S; Zhao C; Li L; Cao W; Yang X; Wei H; Xiao J
Med Sci Monit; 2016 May; 22():1837-42. PubMed ID: 27241212
[TBL] [Abstract][Full Text] [Related]
4. The long non-coding RNA HNF1A-AS1 regulates proliferation and metastasis in lung adenocarcinoma.
Wu Y; Liu H; Shi X; Yao Y; Yang W; Song Y
Oncotarget; 2015 Apr; 6(11):9160-72. PubMed ID: 25863539
[TBL] [Abstract][Full Text] [Related]
5. Gli promotes epithelial-mesenchymal transition in human lung adenocarcinomas.
Li H; Yue D; Jin JQ; Woodard GA; Tolani B; Luh TM; Giroux-Leprieur E; Mo M; Chen Z; Che J; Zhang Z; Zhou Y; Wang L; Hao X; Jablons D; Wang C; He B
Oncotarget; 2016 Dec; 7(49):80415-80425. PubMed ID: 27533453
[TBL] [Abstract][Full Text] [Related]
6. MiR-99a regulates ROS-mediated invasion and migration of lung adenocarcinoma cells by targeting NOX4.
Sun M; Hong S; Li W; Wang P; You J; Zhang X; Tang F; Wang P; Zhang C
Oncol Rep; 2016 May; 35(5):2755-66. PubMed ID: 26986073
[TBL] [Abstract][Full Text] [Related]
7. TLE1 promotes EMT in A549 lung cancer cells through suppression of E-cadherin.
Yao X; Ireland SK; Pham T; Temple B; Chen R; Raj MH; Biliran H
Biochem Biophys Res Commun; 2014 Dec; 455(3-4):277-84. PubMed ID: 25446087
[TBL] [Abstract][Full Text] [Related]
8. MiRNA-145 suppresses lung adenocarcinoma cell invasion and migration by targeting N-cadherin.
Mo D; Yang D; Xiao X; Sun R; Huang L; Xu J
Biotechnol Lett; 2017 May; 39(5):701-710. PubMed ID: 28120164
[TBL] [Abstract][Full Text] [Related]
9. Benzo(a)pyrene promotes migration, invasion and metastasis of lung adenocarcinoma cells by upregulating TGIF.
Yang H; Zhang H; Pan T; Wang H; Wang Y
Toxicol Lett; 2018 Sep; 294():11-19. PubMed ID: 29746904
[TBL] [Abstract][Full Text] [Related]
10. Annexin A3 Knockdown Suppresses Lung Adenocarcinoma.
Liu YF; Liu QQ; Zhang YH; Qiu JH
Anal Cell Pathol (Amst); 2016; 2016():4131403. PubMed ID: 27995049
[TBL] [Abstract][Full Text] [Related]
11. LPP inhibits collective cell migration during lung cancer dissemination.
Kuriyama S; Yoshida M; Yano S; Aiba N; Kohno T; Minamiya Y; Goto A; Tanaka M
Oncogene; 2016 Feb; 35(8):952-64. PubMed ID: 26028032
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic activation of SIN1 promotes NSCLC cell proliferation and metastasis by affecting the epithelial-mesenchymal transition.
Hu Z; Wang Y; Wang Y; Zang B; Hui H; You Z; Wang X
Biochem Biophys Res Commun; 2017 Jan; 483(1):645-651. PubMed ID: 27993679
[TBL] [Abstract][Full Text] [Related]
13. Galectin-1 is overexpressed in CD133+ human lung adenocarcinoma cells and promotes their growth and invasiveness.
Zhou X; Li D; Wang X; Zhang B; Zhu H; Zhao J
Oncotarget; 2015 Feb; 6(5):3111-22. PubMed ID: 25605013
[TBL] [Abstract][Full Text] [Related]
14. NEDD9 promotes lung cancer metastasis through epithelial-mesenchymal transition.
Jin Y; Li F; Zheng C; Wang Y; Fang Z; Guo C; Wang X; Liu H; Deng L; Li C; Wang H; Chen H; Feng Y; Ji H
Int J Cancer; 2014 May; 134(10):2294-304. PubMed ID: 24174333
[TBL] [Abstract][Full Text] [Related]
15. PRKAR1A is a functional tumor suppressor inhibiting ERK/Snail/E-cadherin pathway in lung adenocarcinoma.
Wang S; Cheng Y; Zheng Y; He Z; Chen W; Zhou W; Duan C; Zhang C
Sci Rep; 2016 Dec; 6():39630. PubMed ID: 27995993
[TBL] [Abstract][Full Text] [Related]
16. Glypican-5 suppresses Epithelial-Mesenchymal Transition of the lung adenocarcinoma by competitively binding to Wnt3a.
Wang S; Qiu M; Xia W; Xu Y; Mao Q; Wang J; Dong G; Xu L; Yang X; Yin R
Oncotarget; 2016 Nov; 7(48):79736-79746. PubMed ID: 27806326
[TBL] [Abstract][Full Text] [Related]
17. BCR-ABL-mediated upregulation of PRAME is responsible for knocking down TRAIL in CML patients.
De Carvalho DD; Binato R; Pereira WO; Leroy JM; Colassanti MD; Proto-Siqueira R; Bueno-Da-Silva AE; Zago MA; Zanichelli MA; Abdelhay E; Castro FA; Jacysyn JF; Amarante-Mendes GP
Oncogene; 2011 Jan; 30(2):223-33. PubMed ID: 20838376
[TBL] [Abstract][Full Text] [Related]
18. MGr1-Ag promotes invasion and bone metastasis of small-cell lung cancer in vitro and in vivo.
Zhang F; Wang Y; Xu M; Dong H; Liu N; Zhou J; Pang H; Ma N; Zhang N; Pei Y; Zhang H; Liu L
Oncol Rep; 2013 Jun; 29(6):2283-90. PubMed ID: 23588894
[TBL] [Abstract][Full Text] [Related]
19. Claudin-1 is a metastasis suppressor and correlates with clinical outcome in lung adenocarcinoma.
Chao YC; Pan SH; Yang SC; Yu SL; Che TF; Lin CW; Tsai MS; Chang GC; Wu CH; Wu YY; Lee YC; Hong TM; Yang PC
Am J Respir Crit Care Med; 2009 Jan; 179(2):123-33. PubMed ID: 18787218
[TBL] [Abstract][Full Text] [Related]
20. Ginsenoside Rg3 inhibits epithelial-mesenchymal transition (EMT) and invasion of lung cancer by down-regulating FUT4.
Tian L; Shen D; Li X; Shan X; Wang X; Yan Q; Liu J
Oncotarget; 2016 Jan; 7(2):1619-32. PubMed ID: 26636541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
